REGN7257

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN7257, covering 2025-10-24 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy [Phase 1]

See pricing